STOCKHOLDERS' EQUITY (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
|---|
| STOCKHOLDERS' EQUITY |
|
| Schedule of common stock issued roll forward |
The following table represents a share reconciliation of the Company’s common stock issued for the periods presented: | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2025 | | 2024 | | 2025 | | 2024 | Common stock: | | | | | | | | | Balance, beginning of period | | 197,536,271 | | 186,361,476 | | 195,028,207 | | 183,606,708 | Shares issued for stock options exercised | | 15,870 | | 14,286 | | 72,282 | | 225,444 | Agent growth incentive stock-based compensation | | 859,028 | | 678,825 | | 1,305,685 | | 1,032,513 | Agent equity stock-based compensation | | 3,038,414 | | 2,892,648 | | 5,043,409 | | 5,082,570 | Balance, end of period | | 201,449,583 | | 189,947,235 | | 201,449,583 | | 189,947,235 |
|
| Changes in the Company's stock compensation liability |
The following table illustrates changes in the Company’s stock-based compensation liability for the periods presented: | | | | | Amount | Balance, December 31, 2023 | | $ 5,000 | Stock grant liability increase year to date | | 2,251 | Stock grants reclassified from liability to equity year to date | | (2,206) | Balance, December 31, 2024 | | $ 5,045 | Stock grant liability increase year to date | | 1,149 | Stock grants reclassified from liability to equity year to date | | (928) | Balance, June 30, 2025 | | $ 5,266 |
|
| Schedule of shares repurchased |
The following table shows the share changes in treasury stock for the periods presented (not in thousands): | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2025 | | 2024 | | 2025 | | 2024 | Treasury stock: | | | | | | | | | Balance, beginning of period | | 41,367,141 | | 31,514,913 | | 40,894,822 | | 28,937,671 | Repurchases of common stock | | 2,850,130 | | 4,698,949 | | 3,322,449 | | 7,276,191 | Balance, end of period | | 44,217,271 | | 36,213,862 | | 44,217,271 | | 36,213,862 |
|